These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 6138117

  • 1. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.
    Pullar T, Hunter JA, Capell HA.
    Br Med J (Clin Res Ed); 1983 Oct 15; 287(6399):1102-4. PubMed ID: 6138117
    [Abstract] [Full Text] [Related]

  • 2. Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.
    Bax DE, Amos RS.
    Ann Rheum Dis; 1985 Mar 15; 44(3):194-8. PubMed ID: 2858182
    [Abstract] [Full Text] [Related]

  • 3. Comparisons of sulfasalazine to gold and placebo in the treatment of rheumatoid arthritis.
    Williams HJ.
    J Rheumatol Suppl; 1988 Sep 15; 16():9-13. PubMed ID: 2903928
    [Abstract] [Full Text] [Related]

  • 4. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
    Neumann VC, Grindulis KA, Hubball S, McConkey B, Wright V.
    Br Med J (Clin Res Ed); 1983 Oct 15; 287(6399):1099-102. PubMed ID: 6138116
    [Abstract] [Full Text] [Related]

  • 5. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
    Hull RG, Morgan SH, Parke AL, Childs L, Goldman M, Hughes GR.
    Int J Clin Pharmacol Res; 1984 Oct 15; 4(6):395-401. PubMed ID: 6442711
    [Abstract] [Full Text] [Related]

  • 6. A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis.
    Williams HJ, Ward JR, Dahl SL, Clegg DO, Willkens RF, Oglesby T, Weisman MH, Schlegel S, Michaels RM, Luggen ME.
    Arthritis Rheum; 1988 Jun 15; 31(6):702-13. PubMed ID: 2898244
    [Abstract] [Full Text] [Related]

  • 7. Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone.
    Grindulis KA, McConkey B.
    Ann Rheum Dis; 1984 Jun 15; 43(3):398-401. PubMed ID: 6146295
    [Abstract] [Full Text] [Related]

  • 8. Effects of methotrexate, sulphasalazine and aurothiomalate on polymorphonuclear leucocytes in rheumatoid arthritis.
    Storgaard M, Jensen MP, Stengaard-Pedersen K, Møller BK, Anderson PL, Obel N.
    Scand J Rheumatol; 1996 Jun 15; 25(3):168-73. PubMed ID: 8668961
    [Abstract] [Full Text] [Related]

  • 9. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine.
    Nuver-Zwart IH, van Riel PL, van de Putte LB, Gribnau FW.
    Ann Rheum Dis; 1989 May 15; 48(5):389-95. PubMed ID: 2567150
    [Abstract] [Full Text] [Related]

  • 10. Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy.
    Pullar T, Hunter JA, Capell HA.
    Br J Rheumatol; 1985 Aug 15; 24(3):269-76. PubMed ID: 2861876
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of intramuscular gold and sulphasalazine in the treatment of early rheumatoid arthritis. A one year prospective study.
    Peltomaa R, Paimela L, Helve T, Leirisalo-Repo M.
    Scand J Rheumatol; 1995 Aug 15; 24(6):330-5. PubMed ID: 8610215
    [Abstract] [Full Text] [Related]

  • 14. Serum concentrations of soluble interleukin 2 receptor in patients with rheumatoid arthritis: effect of second line drugs.
    Crilly A, Madhok R, Watson J, Capell HA.
    Ann Rheum Dis; 1993 Jan 15; 52(1):58-60. PubMed ID: 8093995
    [Abstract] [Full Text] [Related]

  • 15. A double-blind controlled study comparing sulphasalazine with placebo in rheumatoid factor (RF)-negative rheumatoid arthritis.
    Farr M, Waterhouse L, Johnson AE, Kitas GD, Jubb RW, Bacon PA.
    Clin Rheumatol; 1995 Sep 15; 14(5):531-6. PubMed ID: 8549091
    [No Abstract] [Full Text] [Related]

  • 16. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.
    Schattenkirchner M, Kaik B, Muller-Fassbender H, Rau R, Zeidler H.
    J Rheumatol Suppl; 1982 Sep 15; 8():184-9. PubMed ID: 6813483
    [Abstract] [Full Text] [Related]

  • 17. Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis.
    Pullar T, Hunter JA, Capell HA.
    Ann Rheum Dis; 1985 Dec 15; 44(12):831-7. PubMed ID: 2867746
    [Abstract] [Full Text] [Related]

  • 18. Sulphasalazine in the treatment of rheumatoid arthritis.
    Pelísková Z, Vácha J, Trnavský K.
    Z Rheumatol; 1985 Dec 15; 44(6):263-6. PubMed ID: 2869625
    [Abstract] [Full Text] [Related]

  • 19. Sulphasalazine for rheumatoid arthritis: relationship between dose, acetylator phenotype and response to treatment.
    Bax DE, Greaves MS, Amos RS.
    Br J Rheumatol; 1986 Aug 15; 25(3):282-4. PubMed ID: 2873862
    [Abstract] [Full Text] [Related]

  • 20. Comparison between sodium aurothiomalate and auranofin in rheumatoid arthritis. Results of a two-year open randomized study.
    Harth M, Davis P, Thompson JM, Menard H, Beaudet F.
    Scand J Rheumatol; 1987 Aug 15; 16(3):177-84. PubMed ID: 3110944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.